Stephens Investment Management Group LLC Sells 198,645 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Stephens Investment Management Group LLC decreased its position in HealthEquity, Inc. (NASDAQ:HQY) by 15.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,050,437 shares of the company’s stock after selling 198,645 shares during the period. HealthEquity accounts for about 1.4% of Stephens Investment Management Group LLC’s investment portfolio, making the stock its 11th biggest position. Stephens Investment Management Group LLC owned approximately 1.21% of HealthEquity worth $100,789,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Raymond James Trust N.A. boosted its stake in shares of HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after purchasing an additional 132 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the period. Truist Financial Corp increased its holdings in shares of HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after acquiring an additional 188 shares during the period. Elk River Wealth Management LLC raised its position in shares of HealthEquity by 0.3% in the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after acquiring an additional 217 shares in the last quarter. Finally, Nicolet Advisory Services LLC lifted its stake in shares of HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Down 0.5 %

HQY stock opened at $111.52 on Friday. The company has a market capitalization of $9.66 billion, a P/E ratio of 102.31, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $113.61. The firm’s fifty day simple moving average is $100.97 and its 200-day simple moving average is $89.67. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the company earned $0.40 EPS. As a group, equities research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Barrington Research boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. BTIG Research upped their price target on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Royal Bank of Canada raised their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Finally, JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $110.71.

Insider Buying and Selling at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the transaction, the director now owns 66,469 shares in the company, valued at $6,750,591.64. This represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.